Giulia Manina
@Giulia_MANINA
Followers
404
Following
290
Media
8
Statuses
112
Paris, France
Joined December 2016
Come join our team at the Institut Pasteur in Paris! We are hiring a postdoc to investigate the single-cell biology of M. tuberculosis. More information is available here:
research.pasteur.fr
Location: Institut Pasteur, Microbial Individuality and Infection (IMI) Unit, Paris, France Duration: 2 years (with potential for renewal) Start Date: The position is immediately available, but the...
1
129
208
Thanks to all partners of the #ANR TREATABLE consortium for their participation and fruitful discussions during our 2nd annual meeting at the Institut Pasteur. Merging #DrugDiscovery, #Microfluidics, and #SingleCells to improve #TB treatment. @CermnUnicaen @Elvesys @Giulia_MANINA
0
1
7
📰 Check out our latest news article describing our recent annual consortium meeting and our first ever joint symposium with fellow @IHIEurope project @UNITE4TB at @UU_University ➡️Read our latest news now: https://t.co/frJLLjz2nZ
#Tuberculosis #TB #TBresearch #drugdevelopment
era4tb.org
1
6
10
🔜Next @BCI_Pasteur seminar next Monday @DrVivekThacker from @UniHeidelberg Plenty of room in the middle’: microphysiologicalmodels as enabling platforms to study infections in tissues Invited by @Giulia_MANINA
0
2
7
To learn more about our paper https://t.co/1qMbLIjuXH, visit this blog post on Research Communities:
communities.springernature.com
Tuberculosis is a main global health threat. We present the µDeSCRiPTor strategy, which combines microfluidic technology with single-cell imaging to capture phenotypic changes in the bacterial...
0
5
8
Delighted to share our latest research on #tuberculosis therapeutics via "pheno-tuning" published in @NatureComms. Read more here: https://t.co/1qMbLIjuXH!
5
10
41
And the ERA4TB 8th Consortium Meeting is over! Thanks to all our partners for their attendance and outstanding contributions during these two days of productive meetings and discussions 👏 @ServInvestUC3M @uppsalauni @GSK_ES @IHIEurope @AMRAccelerator #Tuberculosis
0
8
15
The ERA4TB 8th Consortium Meeting has just kicked off with a welcome by @UlrikaSimonsson and the Project Leadership! Coming up: the latest progression updates and assets forecasts for the next months @uppsalauni @ServInvestUC3M @GSK @IHIEurope @AMRAccelerator
0
4
13
Please RT! We are recruiting! Grant-funded positions to look at a) TB vaccine candidate development and b) TB antibiotic tolerance. Two SRA positions (links in next tweet). Ideal candidate will be curious, hard-working and fun to collaborate with. Full training provided.
5
61
69
Pleased that our preprint is out! Thanks to everyone involved in this project aimed at tackling tuberculosis by targeting phenotypic variation.
biorxiv.org
Drug-recalcitrant infections are a leading global-health concern. Bacterial cells benefit from phenotypic variation, which can suggest effective anti-microbial strategies. However, probing phenotypic...
0
10
45
2
58
141
📆 25-26 January 📍 Paris ERA4TB's 6th Consortium Meeting is just around the corner! Looking forward to meeting in Paris more than 100 partners’ representatives again in this 2-day F2F event to discuss the latest project updates Read more👉 https://t.co/1NGpxARkir
#TB #H2020
0
11
20
Now online our article on #microfluidics and #mycobacterial individuality, @SpringerNature > @SciReports: https://t.co/BM67KWi6xH!
0
7
36
The units of Mariana Alonso, Jean-Baptiste Masson (@IpNeuro) and my core facility have an opening for a join postdoc / engineer! RTs appreciated.
1
36
38
TB deaths are increasing for the first time in over a decade, and we are no longer on track to #endTB by 2030. @Marks1Guy, president at @TheUnion_TBLH, attests that we must re-focus our efforts on new strategies and evidence-based innovations.
'Eliminating tuberculosis by 2030: abandon the goal or revise the strategy?' @Marks1Guy writes about the need to re-focus our efforts and reinvigorate the commitment to #EndTB: https://t.co/JK3CEYDzKL
@MediaplanetUK
0
14
22
Please RT: Postdoctoral position available in mycobacteriology and single-cell technologies in the Microbial Individuality and Infection Lab at the Institut Pasteur in Paris. Please see details below.
2
153
128
Tuberculosis 2022 - preliminary programme is online, have a look- abstract deadline is approaching (May 31st) - looking forward to seeing you in person in Paris in September
4
41
108
Still looking for a few good post docs to join our group working on #TB #vaccines and immunology. Email me joanne@pitt.edu and please retweet. We are a fun group in #Pittsburgh @PittTweet !
3
77
107